These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9784092)

  • 1. Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor.
    Cho N; Harada M; Imaeda T; Imada T; Matsumoto H; Hayase Y; Sasaki S; Furuya S; Suzuki N; Okubo S; Ogi K; Endo S; Onda H; Fujino M
    J Med Chem; 1998 Oct; 41(22):4190-5. PubMed ID: 9784092
    [No Abstract]   [Full Text] [Related]  

  • 2. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.
    Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S
    J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.
    Sasaki S; Cho N; Nara Y; Harada M; Endo S; Suzuki N; Furuya S; Fujino M
    J Med Chem; 2003 Jan; 46(1):113-24. PubMed ID: 12502365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptor.
    Miwa K; Hitaka T; Imada T; Sasaki S; Yoshimatsu M; Kusaka M; Tanaka A; Nakata D; Furuya S; Endo S; Hamamura K; Kitazaki T
    J Med Chem; 2011 Jul; 54(14):4998-5012. PubMed ID: 21657270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.
    Kim SM; Yoo T; Lee SY; Kim EJ; Lee SM; Lee MH; Han MY; Jung SH; Choi JH; Ryu KH; Kim HT
    Life Sci; 2015 Oct; 139():166-74. PubMed ID: 26321528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human growth hormone-releasing hormone on the release of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro.
    Knepel W; Schwaninger M; Wesemeyer G; Döhler KD; Sandow J
    Endocrinology; 1987 Feb; 120(2):732-8. PubMed ID: 2879724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibition.
    Hashimoto K; Kataoka M; Tatsuta M; Yasoshima K; Yamamoto M; Yura T; Yamamoto N; Urbahns K; Gupta JB; Li Y
    Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1314-7. PubMed ID: 16204990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902.
    Struthers RS; Xie Q; Sullivan SK; Reinhart GJ; Kohout TA; Zhu YF; Chen C; Liu XJ; Ling N; Yang W; Maki RA; Bonneville AK; Chen TK; Bozigian HP
    Endocrinology; 2007 Feb; 148(2):857-67. PubMed ID: 17095587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J; Lamharzi N; Halmos G; Groot K; Jungwirth A; Vadillo-Buenfil M; Kakar SS; Schally AV
    Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological properties of chicken luteinizing hormone-releasing hormone: gonadotropin release from rat and chicken cultured anterior pituitary cells and radioligand analysis.
    Hasegawa Y; Miyamoto K; Igarashi M; Chino N; Sakakibara S
    Endocrinology; 1984 Apr; 114(4):1441-7. PubMed ID: 6323147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 3-(2-aminoethyl) uracil derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists.
    Kim SM; Lee M; Lee SY; Lee SM; Kim EJ; Kim JS; Ann J; Lee J; Lee J
    Eur J Med Chem; 2018 Feb; 145():413-424. PubMed ID: 29335207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular mechanisms involved in copper-gonadotropin-releasing hormone (Cu-GnRH) complex-induced cAMP/PKA signaling in female rat anterior pituitary cells in vitro.
    Gajewska A; Zielinska-Gorska M; Wolinska-Witort E; Siawrys G; Baran M; Kotarba G; Biernacka K
    Brain Res Bull; 2016 Jan; 120():75-82. PubMed ID: 26551063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent, nonpeptidyl 1H-quinolone antagonist for the gonadotropin-releasing hormone receptor.
    DeVita RJ; Walsh TF; Young JR; Jiang J; Ujjainwalla F; Toupence RB; Parikh M; Huang SX; Fair JA; Goulet MT; Wyvratt MJ; Lo JL; Ren N; Yudkovitz JB; Yang YT; Cheng K; Cui J; Mount G; Rohrer SP; Schaeffer JM; Rhodes L; Drisko JE; McGowan E; MacIntyre DE; Vincent S; Carlin JR; Cameron J; Smith RG
    J Med Chem; 2001 Mar; 44(6):917-22. PubMed ID: 11300873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II is retained in gonadotrophs of pituitary cell aggregates cultured in serum-free medium but does not mimic the effects of exogenous angiotensins and luteinizing-hormone-releasing hormone on growth hormone release.
    Robberecht W; Andries M; Denef C
    Neuroendocrinology; 1992 Oct; 56(4):550-60. PubMed ID: 1475013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, luteinizing hormone-releasing activity, and receptor binding of chicken hypothalamic luteinizing hormone-releasing hormone.
    Millar RP; King JA
    Endocrinology; 1983 Oct; 113(4):1364-9. PubMed ID: 6311518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of luteinizing hormone release by analogs of luteinizing hormone-releasing hormone (LHRH) in vitro.
    Labrie F; Savary M; Coy DH; Coy EJ; Schally AV
    Endocrinology; 1976 Feb; 98(2):289-94. PubMed ID: 765119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH-receptor interaction. V. Down-regulation of pituitary receptors for GnRH in ovariectomized ewes by infusion of homologous hormone.
    Nett TM; Crowder ME; Moss GE; Duello TM
    Biol Reprod; 1981 Jun; 24(5):1145-55. PubMed ID: 6268204
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolactin inhibits pituitary luteinizing hormone-releasing hormone receptors in the rat.
    Marchetti B; Labrie F
    Endocrinology; 1982 Oct; 111(4):1209-16. PubMed ID: 6288351
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of protein kinase C in facilitation of luteinizing hormone (LH)-releasing hormone-induced LH surges by neuropeptide Y.
    Leupen SM; Levine JE
    Endocrinology; 1999 Aug; 140(8):3682-7. PubMed ID: 10433227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The luteinizing hormone-releasing hormone (LHRH)-desensitized rat pituitary: luteinizing hormone responsiveness to LHRH in vitro.
    Badger TM; Loughlin JS; Naddaff PG
    Endocrinology; 1983 Mar; 112(3):793-9. PubMed ID: 6337047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.